New Investment to Boost Lucideon's Analytical Capabilities in US
Lucideon has invested in a new white light interferometer (WLI) to increase its analytical capabilities at its site in Schenectady, New York, USA.
The new WLI instrument provides flexible measurement and unparalleled performance for a wide range of industries, including medical devices, aerospace, and power generation. The powerful topographical analysis can help to improve product quality and increase productivity, by providing greater insight into product performance and functionality. For example, it can be used to measure wear scars on articulating surfaces and coatings, corrosion pitting, and enamel erosion. As well as being able to provide highly detailed quantitative analysis with a variety of topographical parameters, and an ability to generate 2D and 3D images to visualise the product properties too, WLI requires minimal sample preparation time and fast measurements, making it much more efficient than other surface topography techniques such as profilometry and AFM.
Gemma Budd, healthcare business manager, Lucideon, said:
“White Light Interferometry can measure nano- to macro-features of samples of varying shapes and sizes, including complex geometries. This allows us to provide 3D imagery that is rich in data, with very high resolution, and repeatability that cannot be achieved by contact instrumentation. This level of detail and accuracy is important to our clients who often work at the cutting edge of precision manufacturing and materials innovation, often for complex and critical applications. Unlike contact instrumentation, WLI is completely non-destructive, so our clients don’t lose their samples. Our upgraded instrument and software can now handle much larger degrees of roughness and variability in surface morphology, larger curvature on components, larger sample areas, and make even more measurements including volume loss.
“Surface measurement can be performed for the entire product life-cycle, from design to post-production, helping clients to understand and control manufacturing processes. The investment will increase our ability to characterize extremely diverse sample types, and to characterize surface textures, finishes, roughness, curvature, slope and other features to sub-micron resolution. Measurements can be made with vertical resolutions of just 0.1nm, and the information captured is so detailed that it can be used in the re-optimization of upstream tools and processes, helping to reduce out-of-spec products and waste.”
Lucideon provides materials development, consultancy and analytical services to a wide range of industries, including healthcare. Powerful analytical techniques and data interpretation are key features of Lucideon’s offering to all industries. Its experts go beyond initial testing phases to produce detailed data and interpretation that provides real insight and understanding into its clients’ materials, products and processes.
01 February, 2017